Back

Additional cholesterol synthesis inhibition, CETP inhibitors, and cholesterol-efflux enhancer therapies

30 August 2024 (08:00 - 17:30)
Organised by: Logo
Congress Presentation Part of: Targeting lipids above and beyond statins: key new players Lipid-Lowering Agents ESC Professional Premium Access ESC Congress 2024 European Society of Cardiology

About the speaker

Photo
Professor Ulf Landmesser

Charite University Hospital, Berlin (Germany)

4 More presentations in this session

Presentation thumbnail
PCSK9 inhibition: new insights
Professor L. Raber (Bern, CH)
Slides Video
Presentation thumbnail
Strategies to inhibit Lp(a)
Professor F. Kronenberg (Innsbruck, AT)
Slides Video
Presentation thumbnail
Targeting triglycerides: is it worth it? lessons from recent trials
Associate Professor G. Liuzzo (Rome, IT)
Slides Video
Presentation thumbnail
Targeting lipids above and beyond statins: key new players - discussion
Video

Access the full session

Session thumbnail
Targeting lipids above and beyond statins: key new players
Video

The Event

Event poster

ESC Congress 2024

30 August - 2 September 2024
You may be interested in
thumbnail
Congress Presentation
Effects of lipid-lowering therapies on lipoprotein(a) levels in patients with dyslipidemia: a systematic review and network meta-analysis of 64 randomised controlled trials
thumbnail
Congress Presentation
Where are we now? Decision-making in LDL-C lowering and CV risk
thumbnail
Webinar
Unmet needs in lipid management: treatment goals and how to achieve them

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources